PHILADELPHIA—Undiagnosed early chronic kidney disease (CKD) is highly prevalent among patients with hypertension and cardiovascular disease in the absence of type 2 diabetes (T2D), investigators reported at the American Society of Nephrology’s Kidney Week 2023. Investigators noted that early diagnosis of CKD and active management can slow disease progression and improve outcomes, but the prevalence […]
EvokAI Creative Labs’ Movement Disorder Monitor (MDM) Flex Sensor — which uses artificial intelligence (AI) in monitoring abnormal body movements — has received CE Mark approval in Europe for the management of Parkinson’s disease and other movement disorders. CE Mark approval indicates that the sensor has been assessed by the European Commission, the European Union’s […]
Manganese therapy enables the reversal of atherosclerotic plaque. Credit: Yawei Wang, Xin Feng, Wenjing Zhou, Runze Huang, Yating Hu, Hui Hui, Jie Tian, Xiao Wang, Xiao-Wei Chen Cardiovascular disease (CVD) continue to rank as the top killer in the modern world. This deadly disorder often starts with the buildup of lipid deposits or plaques within […]
Anglia Ruskin University A new study has highlighted a lack of clinical research to address the leading causes of severe sight impairment (SSI) among the working-age UK population, which costs the UK economy an estimated £7.4bn annually. The study, carried out by researchers from Anglia Ruskin University and the University of Oxford, examined how clinical […]
ByHindustan Times Nov 02, 2023 07:02 PM IST Share Via Copy Link This article is authored by Dr Balram Bhargava, chief, Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi. Salt, the humble mineral found in every kitchen and dining table, has an enduring presence in human history. Its value as a commodity has […]
After Erica Jedynak gave birth to her only child in 2021, she tried to opt out of the “heel-prick” test hospitals routinely do on newborns to detect disease. The nurse insisted it was mandatory, the test turned up nothing, and Jedynak mostly forgot about it in the chaos of new parenthood. But after the Boonton […]
— Growing body of data on REZLIDHIA® (olutasidenib) in mIDH1 relapsed or refractory (R/R) acute myeloid leukemia (AML) patients — — New data on olutasidenib in patients with mIDH1 myelodysplastic syndromes/neoplasms (MDS) — SOUTH SAN FRANCISCO, Calif., Nov. 2, 2023 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the upcoming presentation of four posters highlighting […]
Cancer and neoplasms
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients
02
Nov
Nov
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients
Oral presentation will showcase distinct preclinical profile for potent, selective MALT1 scaffolding inhibitor that is highly differentiated from MALT1 protease inhibitors BOSTON, Nov. 2, 2023 /PRNewswire/ — HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as “natural hotspots,” today […]
2022 saw myriad ups and downs in terms of the economy, and as it ebbed and flowed, so too did the job market. This trend has continued throughout 2023. The year kicked off with mass layoffs in the tech industry, leaving many wondering if the same was in store for the biopharma industry. Fortunately, though […]